Lin, J. et al. Associations of proteomics with hypertension and systolic blood pressure: KORA S4/F4/FF4 and KORA-Age1/Age2 Cohort Studies. Hypertension 81, 1156-1166 (2024)
Gong, S.* et al. Primary aldosteronism: Spatial multi-omics mapping of genotype-dependent heterogeneity and tumor expansion of aldosterone-producing adenomas.  Hypertension 80, 1555-1567 (2023)
Thürmann, L.* et al. Undiagnosed pediatric elevated blood pressure is characterized by induction of pro-inflammatory and cytotoxic mediators. Hypertension 80, 2425-2436 (2023)
Vishram-Nielsen, J.K.K.* et al. Predictive importance of blood pressure characteristics with increasing age in healthy men and women: The MORGAM Project. Hypertension 77, 1076-1085 (2021)
Sun, N. et al. Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism. Hypertension 75, 634-644 (2020)
Vishram-Nielsen, J.K.K.* et al. Does estimated pulse wave velocity add prognostic information? MORGAM prospective cohort project. Hypertension 75, 1420-1428 (2020)
Vohra, T.* et al. Effect of dietary sodium modulation on pig adrenal steroidogenesis and transcriptome profiles. Hypertension 76, 1769-1777 (2020)
Wain, L.V.* et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension 70, e4-e19 (2017)
Zeller, T.* et al. Transcriptome-wide analysis identifies novel associations with blood pressure. Hypertension 70, 713-750 (2017)
Menni, C.* et al. Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension 66, 422-429 (2015)
Fernandes-Rosa, F.L.* et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354-361 (2014)
Spyroglou, A.* et al. Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion. Hypertension 63, 1102-1109 (2014)
Lieb, W.* et al. Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 61, 995-1001 (2013)
Dreger, H.* et al. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Hypertension 60, 1176-1183 (2012)
Mulatero, P.* et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59, 235-240 (2012)
Reincke, M.* et al. Observational study mortality in treated primary aldosteronism: The German Conn's registry. Hypertension 60, 618-624 (2012)
Bähr, I.N.* et al. High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome. Hypertension 58, 725-732 (2011)
Tabara, Y.* et al. Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: The Japanese millennium genome project. Hypertension 56, 973-980 (2010)
Baessler, S.* et al. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: Results of the MONICA/KORA Augsburg echocardiographic substudy. Hypertension 47, 920-927 (2006)
Mayer, B.* ; Döring, A. & Löwel, H. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 46, 766-771 (2005)
Luchner, A.* et al. N-Terminal Pro-Brain Natriuretic Peptide after Myocardial Infarction : A Marker of Cardio-Renal Function. Hypertension 39, 99-104 (2002)
Hengstenberg, C.* et al. Evaluation of the Aldosterone Synthase (CYP11B2) Gene Polymorphism in Patients with Myocardial Infarction. Hypertension 35, 704-709 (2000)
Cairns, V. ; Keil, U. ; Kleinbaum, D.G. ; Doering, A.* & Stieber, J.* Alcohol consumption as a risk factor for high blood pressure. Munich blood pressure study. Hypertension 6, 124-131 (1984)